Microorganisms can group together on a surface to form collections of cells called biofilms; one example of this is dental plaque. Grouping together as a community protects these cells from environments which they may not be able to survive alone, such as the wrong pH or a lack of water or oxygen. Biofilms may be made up of many different species of microorganism and these species may be varied further by strain. In a recent paper, Caitlin Kowalski and colleagues at the Geisel School of Medicine at Dartmouth, USA, studied the ability of Aspergillus fumigatus biofilms to grow in low oxygen environments and cause invasive aspergillosis in mice.
Kowalski and colleagues exposed A. fumigatus to low levels of oxygen, which reflect the levels found in the lesions where the fungus grows in the lung, in order to identify genes and mechanisms involved in allowing the pathogen to grow under these conditions. They then discovered a specific mutation which allowed the strain to both grow better in low oxygen, but also cause disease better under these conditions. It remains to be discovered how this particular mutation allows the strain to grow more successfully and be more virulent in low oxygen. However in other fungal biofilms, for example the yeast Candida albicans, the colony can form wrinkles which improve oxygen penetration. Understanding how the structure of biofilm colony growth reflects advantages in the ability of the fungus to cause disease may allow clinicians and scientists to better predict the progression of disease and improve patient care.
Find out more:
Share this post
Latest News posts
Aspergillosis monthly patient & carer meeting
April 7, 2021
COVID Vaccination – hesitating?
February 24, 2021
What is an MDT?
February 17, 2021
Aspergillosis Weekly Support Meeting
February 15, 2021
An aspergillosis diagnostic journey
February 5, 2021
Aspergillosis Monthly Patient & Carer Meeting
February 5, 2021
World Aspergillosis Day 2021
February 2, 2021
World Aspergillosis Day, 1 February 2021
January 28, 2021
COVID Vaccine for Aspergillosis Patients
December 11, 2020
COVID Precautions for the extremely vulnerable: Winter 2020
November 23, 2020
News archive
- Antifungals in development
- COVID-19
- Events
- Fundraising
- General interest
- How do I...?
- Information and Learning
- Latest research news
- Lifestyle and Coping Skills
- Living with Aspergillosis
- NAC announcements
- News archive
- Patient and Carer Blog
- Patient stories
- Recordings
- Supplements and complementary therapies
- Types of aspergillosis
- Video